Progressive Metabolic Adaptations to Low Intensity Exercise Training and Weight Loss
- Full Text View
- Tabular View
- No Study Results Posted
- Disclaimer
- How to Read a Study Record
Purpose
the investigators first aim is to determine the effect of low intensity exercise (without weight loss) on insulin sensitivity, muscle lipid metabolism, and factors regulating these processes in skeletal muscle after 1 day, 2 wks, 12 wks of training, and again after 3 days without exercise in obese adults. the investigators second aim is to determine the effect of combining low intensity exercise training with 10% weight loss on insulin sensitivity, muscle lipid metabolism, and factors regulating these processes in skeletal muscle.
Although a single 40 minute session of exercise at a low exercise intensity will not improve insulin sensitivity, the investigators anticipate adaptations after two weeks of exercise training (6 session/wk; 12 session total) will improve insulin sensitivity and be accompanied by a reduction in fatty acid intermediates and a reduction in markers for pro-inflammatory activation in muscle. the investigators anticipate changes in insulin sensitivity, fatty acid partitioning, and pro-inflammatory markers the day after the last session of a 12 wk training program (without weight-loss) will be similar to that measured after 2 weeks of training. the investigators anticipate insulin sensitivity, accumulation of fatty acid intermediates, and pro-inflammatory activation will be markedly improved after 10% weight loss when measured the day after exercise. the investigators would expect the improvements in Insulin sensitivity, accumulation of fatty acid intermediates, and markers of inflammatory stress will be significantly attenuated when measured 3 days after the most recent exercise session, but beneficial effects of 10% weight loss on these metabolic endpoints will persist when compared with before weight loss.
| Condition | Intervention |
|---|---|
|
Obesity |
Other: Exercise Training Other: Weight Loss with continued Exercise Training |
| Study Type: | Interventional |
| Study Design: | Endpoint Classification: Efficacy Study Intervention Model: Single Group Assignment Masking: Open Label Primary Purpose: Basic Science |
- Insulin Sensitivity [ Time Frame: 2-3 hours ] [ Designated as safety issue: No ]A hyperinsulinemic-euglycemic clamp will be used to assess peripheral insulin sensitivity
- Resting Metabolic Rate [ Time Frame: 20-30 min ] [ Designated as safety issue: No ]
- Meal Tolerance Test [ Time Frame: 2-3h ] [ Designated as safety issue: No ]
| Estimated Enrollment: | 16 |
| Study Start Date: | July 2011 |
| Estimated Study Completion Date: | April 2016 |
| Estimated Primary Completion Date: | April 2014 (Final data collection date for primary outcome measure) |
| Arms | Assigned Interventions |
|---|---|
|
Exercise Training with Weight Loss
During the first 12 weeks of the study, subjects will adhere to an exercise training program while maintaining their original body weight. The exercise training program will entail the following: 40min/session, ~50% of their maximal aerobic capacity (approximately 100-110 beats per min), 5-6 days/week After the first 12 weeks in the study, subjects will continue with the same exercise program, but then they will be placed on a reduced calorie diet until they lose exactly 10% of their original body weight |
Other: Exercise Training
During the first 12 weeks of the study, subjects will adhere to an exercise training program while maintaining their original body weight. The exercise training program will entail the following: 40min/session, ~50% of their maximal aerobic capacity (approximately 100-110 beats per min), 5-6 days/week
Other: Weight Loss with continued Exercise Training
After the first 12 weeks in the study, subjects will continue with the same exercise program, but then they will be placed on a reduced calorie diet until they lose exactly 10% of their original body weight
|
Eligibility| Ages Eligible for Study: | 18 Years to 45 Years |
| Genders Eligible for Study: | Both |
| Accepts Healthy Volunteers: | Yes |
Inclusion Criteria:
- body mass index [BMI]: 30-45 kg/m2; All women must be pre-menopausal; Non-exerciser (no regularly planned exercise/physical activity)
Exclusion Criteria:
- Hematocrit ≤ 34%; Fasting plasma glucose concentration ≥ 125 mg/dL; Weight instability ≥ ±5 lbs in past month; Taking medications known to affect lipid and/or glucose metabolism; evidence and/or history of cardiovascular or frank metabolic diseases; pregnancy or actively breast feeding
Contacts and Locations| Contact: Suzette Howton, RD | 734-647-9850 | suzetter@med.umich.edu |
| United States, Michigan | |
| Michigan Clincal Research Unit | Recruiting |
| Ann Arbor, Michigan, United States, 48109 | |
| Contact: Suzette Howton, RD 734-647-9850 suzetter@med.umich.edu | |
| Principal Investigator: Jeffrey F Horowitz, Ph.D. | |
| Principal Investigator: | Jeffrey F Horowitz | University of Michigan |
More Information
No publications provided
| Responsible Party: | JEFFREY F HOROWITZ, Associate Professor, Movement Science, School of Kinesiology, University of Michigan |
| ClinicalTrials.gov Identifier: | NCT01452074 History of Changes |
| Other Study ID Numbers: | R01 DK077966 - PA, R01DK077966 |
| Study First Received: | October 11, 2011 |
| Last Updated: | December 14, 2012 |
| Health Authority: | United States: Institutional Review Board |
Keywords provided by University of Michigan:
|
Insulin Sensitivity Exercise Training Weight Loss Fat Metabolism |
Additional relevant MeSH terms:
|
Obesity Weight Loss Overnutrition Nutrition Disorders |
Overweight Body Weight Signs and Symptoms Body Weight Changes |
ClinicalTrials.gov processed this record on June 17, 2013